DADC
FTXH icon

D.A. Davidson & Co’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

D.A. Davidson & Co’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-239,586
Closed -$6.33M – 1313
2022
Q2 		$6.33M Buy
+239,586
New +$6.33M 0.08% 206

Other funds holding FTXH

Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
WFA
WMG Financial Advisors Knoxville, Tennessee $265M AUM 26.03% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $631M AUM 27.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.A. Davidson & Co's FTXH Position: Q3 2022 in Review

D.A. Davidson & Co sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q3 2022, closing a stake of 239,586 shares — an estimated $6.33M sold.

D.A. Davidson & Co first reported a position in FTXH in Q2 2022 and held it in 1 quarter. The position peaked at $6.33M in Q2 2022. 26 funds tracked by Wall St. Rank hold FTXH as of Q3 2022.

  • D.A. Davidson & Co reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q3 2022 after selling out during the quarter.
  • D.A. Davidson & Co sold 239,586 First Trust Nasdaq Pharmaceuticals ETF shares in Q3 2022, an estimated $6.33M.
  • D.A. Davidson & Co first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2022 and held it in 1 quarter.
  • D.A. Davidson & Co's First Trust Nasdaq Pharmaceuticals ETF position peaked at $6.33M in Q2 2022.
  • 26 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q3 2022.

Based on D.A. Davidson & Co's 13F filing for Q3 2022, filed 7 Nov 2022.